Company Data
Xenetic Biosciences Inc.
Ticker
XBIO
Current Price
$3.904 -2.76%
Market Cap
$6.0M
Price Target
Refer to Report
Volume
2.6K
52wk Range
$2.55 - $5.97
Overview
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.